Clinical Operations Services

 

Careers Header_Desktop Careers Header_Desktop

Clinical operations are the key component behind successful clinical research, who are responsible for designing, conducting, and managing Phase I – IV trials.

As clinical trials have become more complex due to increased guidance and regulations, there's more pressure than ever on clinical operations teams. While some organizations may put more time and effort into this area, others are outsourcing their clinical trials to CROs with deep expertise in the particular field of research and that provide robust, end-to-end services to execute their trials successfully.

Our clinical operations team will work with you to optimize clinical trial design, implement patient-centric approaches, and guide you through the entire clinical development lifecycle. Learn how our experts can help in the multi-phase development of your clinical operations.

How Outsourcing Clinical Operations Can Help at Each Phase of Clinical Trials

No matter where you are in the clinical development process, our clinical operations team can help. At each phase of clinical trials, we will provide expert guidance to lead you to the next phase and ultimately a successful outcome with the appropriate regulatory agency.

Phase I Services

We provide teams with clinical expertise and an extended suite of early-phase clinical development services specifically engineered to accelerate study progression. Together, our clinical operations team will successfully lead and execute your proof-of-concept study to Phase 2 trial.

Phase II and III Services

We customize solutions using our comprehensive lineup of clinical operations services and a select team that understands your needs. Whether tackling the issue of an under-resourced company infrastructure or working on a novel therapy or trial design, ProPharma’s Clinical Ops team will get it done effectively and efficiently.

Phase IIIb and IV Services

The longevity of late-stage development studies within observational research and registry development requires dedicated resources. Our specialized clinical operations leaders have a wealth of experience in late-stage development and health outcomes. We will provide the support you need for the duration of the study.

Medical Devices and Diagnostics

Our team of experts provides support for the entire product lifecycle – from clinical study design and execution to on-market support to meet global regulations.

Our Key Clinical Operations-Related Service Offerings Include:

Work With Our Experienced Clinical Operations Experts

Our clinical operations leaders have the expertise to help you design, conduct, and manage clinical trials for drugs and medical devices. Whether you need a partner to assist internal teams with the workload or outsource your entire clinical trial, our experts are here to provide support. Contact our team today to learn more about our clinical operations services.

News & Insights

Reclaiming the European Market: How to Secure EU/UK MAH Status Without the Local Infrastructure

November 6, 2025

Reclaiming the European Market: How to Secure EU/UK MAH Status Without the Local...

Discover how non-European pharma companies can quickly and compliantly secure EU/UK Marketing Authorisation Holder status without local infrastructure, ensuring market success.

FDA Tightens the Reins on DTC Drug Ads: Big Picture Insights and Industry Implications

October 28, 2025

FDA Tightens the Reins on DTC Drug Ads: Big Picture Insights and Industry Implic...

FDA issues 61 enforcement letters targeting deceptive drug advertising. Explore key trends, efficacy violations, and CCN compliance insights.

How Mature Are Your Data Integrity Practices?  New FDA and EU Regulatory Focus Areas

October 23, 2025

How Mature Are Your Data Integrity Practices?  New FDA and EU Regulatory Focus A...

Explore the evolving regulatory landscape in data integrity with FDA and EU 2025 updates, focusing on digital systems, AI, and stringent compliance measures.

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Article Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption - ProPharma

November 7, 2025

Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption

U.S. tariff policies are shifting fast and pharma companies dependent on global supply chains are feeling the strain. With new tariffs on APIs, excipients, and finished drug products climbing as high...

Article The Relevance of AI in Medical Information: Transforming Communication, Compliance, and Care - ProPharma

November 5, 2025

The Relevance of AI in Medical Information: Transforming Communication, Complian...

Artificial intelligence (AI) is no longer a future concept — it’s transforming Medical Information (MI) today. In a field where accuracy, empathy, and speed define trust, AI is emerging not just as a...

Article Improving Patient Health and Safety through Pharmacovigilance and Medical Information Synergy - ProPharma

October 30, 2025

Improving Patient Health and Safety through Pharmacovigilance and Medical Inform...

In today’s data-driven pharmaceutical landscape, patient safety depends on more than vigilance — it demands collaboration. Pharmacovigilance and Medical Information teams are no longer operating in...

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

November 18, 2025

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

Tips for Successful MAA Submissions in Europe

November 11, 2025

Tips for Successful MAA Submissions in Europe

Navigate the complexities of EU marketing authorization to explore tips for successful Marketing Authorization Application (MAA) submissions in Europe to ensure proven strategies, reduced delays, and...

AI in Medical Information: Who Holds the Responsibility?

October 16, 2025

AI in Medical Information: Who Holds the Responsibility?

In Medical Information (MI) and beyond, key questions arise: Who ensures accuracy, compliance, and ethical use — individual contributors, leadership, pharma clients, or technology providers? And what...

News & Insights

Reclaiming the European Market: How to Secure EU/UK MAH Status Without the Local Infrastructure

November 6, 2025

Reclaiming the European Market: How to Secure EU/UK MAH Status Without the Local...

Discover how non-European pharma companies can quickly and compliantly secure EU/UK Marketing Authorisation Holder status without local infrastructure, ensuring market success.

FDA Tightens the Reins on DTC Drug Ads: Big Picture Insights and Industry Implications

October 28, 2025

FDA Tightens the Reins on DTC Drug Ads: Big Picture Insights and Industry Implic...

FDA issues 61 enforcement letters targeting deceptive drug advertising. Explore key trends, efficacy violations, and CCN compliance insights.

How Mature Are Your Data Integrity Practices?  New FDA and EU Regulatory Focus Areas

October 23, 2025

How Mature Are Your Data Integrity Practices?  New FDA and EU Regulatory Focus A...

Explore the evolving regulatory landscape in data integrity with FDA and EU 2025 updates, focusing on digital systems, AI, and stringent compliance measures.

Previous Post Arrow Next Post Arrow
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Article Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption - ProPharma

November 7, 2025

Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption

U.S. tariff policies are shifting fast and pharma companies dependent on global supply chains are feeling the strain. With new tariffs on APIs, excipients, and finished drug products climbing as high...

Article The Relevance of AI in Medical Information: Transforming Communication, Compliance, and Care - ProPharma

November 5, 2025

The Relevance of AI in Medical Information: Transforming Communication, Complian...

Artificial intelligence (AI) is no longer a future concept — it’s transforming Medical Information (MI) today. In a field where accuracy, empathy, and speed define trust, AI is emerging not just as a...

Article Improving Patient Health and Safety through Pharmacovigilance and Medical Information Synergy - ProPharma

October 30, 2025

Improving Patient Health and Safety through Pharmacovigilance and Medical Inform...

In today’s data-driven pharmaceutical landscape, patient safety depends on more than vigilance — it demands collaboration. Pharmacovigilance and Medical Information teams are no longer operating in...

Previous Resource Arrow Next Resource Arrow
Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

November 18, 2025

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

Tips for Successful MAA Submissions in Europe

November 11, 2025

Tips for Successful MAA Submissions in Europe

Navigate the complexities of EU marketing authorization to explore tips for successful Marketing Authorization Application (MAA) submissions in Europe to ensure proven strategies, reduced delays, and...

AI in Medical Information: Who Holds the Responsibility?

October 16, 2025

AI in Medical Information: Who Holds the Responsibility?

In Medical Information (MI) and beyond, key questions arise: Who ensures accuracy, compliance, and ethical use — individual contributors, leadership, pharma clients, or technology providers? And what...

Previous Webinar Arrow Next Webinar Arrow